Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Torchmark in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Torchmark. This N/A consensus rating has held steady for over two years.
Torchmark Corporation, through its subsidiaries, provides various life and health insurance products, and annuities in the United States, Canada, and New Zealand. It operates through four segments: Life Insurance, Health Insurance, Annuity, and Investment. The company offers traditional and interest-sensitive whole life insurance, as well as term life insurance. It also provides health insurance product, including Medicare Supplement, critical illness, accident, and limited-benefit supplemental hospital and surgical coverage; and annuities, such as single-premium and flexible-premium deferred annuities. The company sells its products through sales by direct response, exclusive agents, and independent agents, as well as through direct mail, electronic media, and insert media. Torchmark Corporation was founded in 1900 and is headquartered in McKinney, Texas.
Read More